Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 101–200 of 1,004
Lundström, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.144 · Cited by 283
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators
Duffney, L. J., Zhong, P., Wei, J., Matas, E., Cheng, J., Qin, L., Ma, K., Dietz, D. M., Kajiwara, Y., Buxbaum, J. D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.064 · Cited by 281
“Shank3-Deficient Mice Exhibit ASD-like Behaviors and Impaired NMDAR Function in Prefrontal Cortex To determine the impact of Shank3 deficiency on autism-like behaviors, we used heterozygous mice with C-terminal deleted Shank3 (deletion of exon 21, which includes the Homer- and Cortactin-binding domains), Shank3, since…”
InfluentialThe genetic basis of non-syndromic intellectual disability: a review
Kaufman, L., Ayub, M., & Vincent, J. B. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9055-2 · Cited by 279
“SHANK3 has also been found to cause autism in several studies (Durand et al. 2007; Marshall et al. 2008).”
Heterogeneous dysregulation of microRNAs across the autism spectrum
Abu-Elneel, K., Liu, T., Gazzaniga, F. S., Nishimura, Y., Wall, D. P., Geschwind, D. H., Lao, K., & Kosik, K. S. (2008) · neurogenetics · doi:10.1007/s10048-008-0133-5 · Cited by 271
Synaptic Signaling in Learning and Memory
Kennedy, M. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016824 · Cited by 270
“In humans and in mice, deletion of SHANK scaffold proteins has been repeatedly linked to autistic behaviors (Durand et al. 2007; Herbert 2011; Peca et al. 2011).”
BackgroundBrain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors
Wei, H., Chadman, K. K., McCloskey, D. P., Sheikh, A. M., Malik, M., Brown, W. T., & Li, X. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.01.011 · Cited by 259
Human Structural Variation: Mechanisms of Chromosome Rearrangements
Weckselblatt, B., & Rudd, M. K. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.05.010 · Cited by 257
Martínez‐Cerdeño, V. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22417 · Cited by 256
“Mutations of the Shank family of scaffold proteins, in particular Shank3, are linked to a familial form of autism (Durand et al., 2007).”
The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology
Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254
Atypical behaviour and connectivity in SHANK3-mutant macaques
Zhou, Y., Sharma, J., Ke, Q., Landman, R., Yuan, J., Chen, H., Hayden, D. S., Fisher, J. W., Jiang, M., Menegas, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1278-0 · Cited by 251
Lin, Y.-C., & Koleske, A. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153204 · Cited by 248
“Mutations of shank3 are linked to Autism spectrum disorders, suggesting that the failure of Shank/Homer-induced synapse stabilization may have significant consequences during brain development in humans (Durand et al. 2007).”
InfluentialSYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function
Fassio, A., Patry, L., Congia, S., Onofri, F., Piton, A., Gauthier, J., Pozzi, D., Messa, M., Defranchi, E., Fadda, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr122 · Cited by 240
de Chaumont, F., Ey, E., Torquet, N., Lagache, T., Dallongeville, S., Imbert, A., Legou, T., Le Sourd, A.-M., Faure, P., Bourgeron, T., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0396-1 · Cited by 240
Self-citationPersico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 238
“They re frequently inherited from an apparently healthy parent and an also be found in unaffected siblings of probands with autism. wo de novo mutations, R536W and R1117X, never reported in SD patients, were detected in individuals with schizophrenia [78]. otably, autistic carriers of inherited 22q13 deletions involvi…”
BackgroundFilice, F., Vörckel, K. J., Sungur, A. Ö., Wöhr, M., & Schwaller, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0192-8 · Cited by 240
“In individuals with ASD or schizophrenia patients with ASD traits, mutations were repeatedly reported for all SHANK gene family members [4, 9, 11, 12], namely SHANK1 [13], SHANK2 [14–16] and SHANK3 [17–21].”
BackgroundQin, L., Ma, K., Wang, Z.-J., Hu, Z., Matas, E., Wei, J., & Yan, Z. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0110-8 · Cited by 240
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
Boccuto, L., Lauri, M., Sarasua, S. M., Skinner, C. D., Buccella, D., Dwivedi, A., Orteschi, D., Collins, J. S., Zollino, M., Visconti, P., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.175 · Cited by 240
The emerging role of SHANK genes in neuropsychiatric disorders
Guilmatre, A., Huguet, G., Delorme, R., & Bourgeron, T. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22128 · Cited by 237
“The breakpoint is located in a short genomic region, highly rich in guanine and with a high probability of being in a G-quartet conformation (Durand et al., 2007).”
BackgroundSelf-citationA standardized social preference protocol for measuring social deficits in mouse models of autism
Rein, B., Ma, K., & Yan, Z. (2020) · Nature Protocols · doi:10.1038/s41596-020-0382-9 · Cited by 232
Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons
Griesi-Oliveira, K., Acab, A., Gupta, A. R., Sunaga, D. Y., Chailangkarn, T., Nicol, X., Nunez, Y., Walker, M. F., Murdoch, J. D., Sanders, S. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.141 · Cited by 236
The pathophysiology of restricted repetitive behavior
Lewis, M., & Kim, S.-J. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9019-6 · Cited by 234
“3 deletion syndrome but has yet to be implicated in RRB [113].”
BackgroundPostsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies
Grabrucker, A. M., Schmeisser, M. J., Schoen, M., & Boeckers, T. M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.07.003 · Cited by 233
Self-citationGenomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 229
Steinman, K. J., Spence, S. J., Ramocki, M. B., Proud, M. B., Kessler, S. K., Marco, E. J., Green Snyder, L., D'Angelo, D., Chen, Q., Chung, W. K., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37820 · Cited by 218
“…Ohta et al., 1999; Huppke et al., 2000; Lossie et al., 2001; Anderlid et al., 2002; Wilson et al., 2003; Van Esch et al., 2005; Sahoo et al., 2006; Durand et al., 2007; Okamoto et al., 2007; Christian et al., 2008; Ramocki et al., 2009; Dhar et al., 2010; Christodoulou and Ho, 2012; Han et al.,…”
Hussman, J. P., Chung, R.-H., Griswold, A. J., Jaworski, J. M., Salyakina, D., Ma, D., Konidari, I., Whitehead, P. L., Vance, J. M., Martin, E. R., et al. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-1 · Cited by 231
“Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.”
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation
Grabrucker, A. M., Knight, M. J., Proepper, C., Bockmann, J., Joubert, M., Rowan, M., Nienhaus, G. U., Garner, C. C., Bowie, J. U., Kreutz, M. R., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.336 · Cited by 228
“With regard to excitatory synaptic function, muta- tions in the ProSAP/Shank family are perhaps some of the most exciting given their link to autism spectrum disorders (Durand et al, 2007; Berkel et al, 2010) and Alzheimer’s disease (Gong et al, 2009; Roselli et al, 2009; Pham et al, 2010).”
BackgroundSelf-citationSarachana, T., Zhou, R., Chen, G., Manji, H. K., & Hu, V. W. (2010) · Genome Medicine · doi:10.1186/gm144 · Cited by 228
Early hyperactivity and precocious maturation of corticostriatal circuits in Shank3B−/− mice
Peixoto, R. T., Wang, W., Croney, D. M., Kozorovitskiy, Y., & Sabatini, B. L. (2016) · Nature Neuroscience · doi:10.1038/nn.4260 · Cited by 227
Protein interactome reveals converging molecular pathways among autism disorders
Sakai, Y., Shaw, C. A., Dawson, B. C., Dugas, D. V., Al-Mohtaseb, Z., Hill, D. E., & Zoghbi, H. Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002166 · Cited by 226
Bonaglia, M. C., Giorda, R., Beri, S., De Agostini, C., Novara, F., Fichera, M., Grillo, L., Galesi, O., Vetro, A., Ciccone, R., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002173 · Cited by 224
“In contrast, 9 cases with terminal 140 kb deletion and a breakpoint occurring in a short GC-rich simple repeat in intron 8 of the SHANK3 gene have been reported [18,19,25,30,38,39].”
BackgroundYirmiya, N., & Charman, T. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02214.x · Cited by 222
“The direct sequencing approach has identified several coding mutations associated with autism including genes encoding neuroligins and their associated proteins that are important in synaptic function (Durand et al., 2007; Jamain et al., 2003; Laumonnier et al., 2004; Szatmari et al., 2007).”
BackgroundEl-Ansary, A., & Al-Ayadhi, L. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0189-0 · Cited by 224
Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice
Peter, S., ten Brinke, M. M., Stedehouder, J., Reinelt, C. M., Wu, B., Zhou, H., Zhou, K., Boele, H.-J., Kushner, S. A., Lee, M. G., et al. (2016) · Nature Communications · doi:10.1038/ncomms12627 · Cited by 224
Self-citationPhelan, M. C. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-14 · Cited by 221
Wöhr, M., Roullet, F. I., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020631 · Cited by 220
“As in the present study, a female bias was reported instead [6,8,10].”
ResultSociability and motor functions in Shank1 mutant mice
Silverman, J. L., Turner, S. M., Barkan, C. L., Tolu, S. S., Saxena, R., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.026 · Cited by 218
Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders
Tabouy, L., Getselter, D., Ziv, O., Karpuj, M., Tabouy, T., Lukic, I., Maayouf, R., Werbner, N., Ben-Amram, H., Nuriel-Ohayon, M., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.05.015 · Cited by 214
Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients · doi:10.3390/nu11112812 · Cited by 214
“The genetic factors affecting ASD are very heterogeneous [9,10] and there are few genes whose association to ASD have been well characterized [11,12], for example SH3 and multiple ankyrin repeat domain 3 (SHANK3) [11,13–15], contactin associated protein-like 2 (CNTNAP2) [16,17], and more recently, chromodomain helicas…”
BackgroundExcitation control: balancing PSD-95 function at the synapse
Keith, D. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.004.2008 · Cited by 210
“Changes in the recruitment and/ or assembly of PSD-95/GKAP/Shank/cortactin complex may provide a mechanism for mediating the structural changes associated with changes in synaptic plasticity.”
BackgroundInfluentialA Short Review on the Current Understanding of Autism Spectrum Disorders
Park, H. R., Lee, J. M., Moon, H. E., Lee, D. S., Kim, B.-N., Kim, J., Kim, D. G., & Paek, S. H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.1.1 · Cited by 210
“SHANK3 [136] 22q13.”
Rare Deletions at the Neurexin 3 Locus in Autism Spectrum Disorder
Vaags, A. K., Lionel, A. C., Sato, D., Goodenberger, M., Stein, Q. P., Curran, S., Ogilvie, C., Ahn, J. W., Drmic, I., Senman, L., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.025 · Cited by 209
Genetics of autistic disorders: review and clinical implications
Freitag, C. M., Staal, W., Klauck, S. M., Duketis, E., & Waltes, R. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0076-x · Cited by 208
“Similar to reports of mutations of X-chromosomal genes (see below), SHANK3 mutations might cause a monogenic form of non-verbal or severely speech delayed AD [23, 30, 56].”
Araç, D., Boucard, A. A., Özkan, E., Strop, P., Newell, E., Südhof, T. C., & Brunger, A. T. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.002 · Cited by 207
“Consistent with this notion, mutations in Shank3, a postsynaptic scaffolding molecule that indirectly interacts with NLs, were also found in autism spectrum disorders (Durand et al., 2007).”
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 206
“stop, R26W, P208S, R462X, T1127M, A1350T, L1008_P1009dup 396 ASD cases, 184 MR cases, 659 controls Case/control Canadian for ASD, German for MR Berkel et al., 2010 R443C, R598L, V717F, A729T, E1162K, G1170R, V1376I, D1535N, L1722P 851 ASD cases, 1090 controls Case/control Paris Autism Research International Sibpair (P…”
BackgroundGatto (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00004 · Cited by 204
“Mutations in SHANK3 are linked to autism (Durand et al., 2007; Moessner et al., 2007).”
Blundell, J., Tabuchi, K., Bolliger, M. F., Blaiss, C. A., Brose, N., Liu, X., Südhof, T. C., & Powell, C. M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00455.x · Cited by 204
“…et al. 2004; Comoletti et al. 2004; Jamain et al. 2003; Laumonnier et al. 2004; Yan et al. 2005), and three different nonsense mutations in SHANK3 (Durand et al. 2007), a synaptic scaffolding protein associated with NLs intracellularly (Meyer et al. 2004), have been found in patients with ASDs.”
BackgroundCasey, J. P., Magalhaes, T., Conroy, J. M., Regan, R., Shah, N., Anney, R., Shields, D. C., Abrahams, B. S., Almeida, J., Bacchelli, E., et al. (2012) · Human Genetics · doi:10.1007/s00439-011-1094-6 · Cited by 200
Self-citationDe Rubeis, S., Siper, P. M., Durkin, A., Weissman, J., Muratet, F., Halpern, D., Trelles, M. D. P., Frank, Y., Lozano, R., Wang, A. T., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0205-9 · Cited by 199
“Protein domains are from UniProt; the homer and cortactin binding sites are indicated as previously reported [9].”
BackgroundInfluentialSelf-citationVerpelli, C., Dvoretskova, E., Vicidomini, C., Rossi, F., Chiappalone, M., Schoen, M., Di Stefano, B., Mantegazza, R., Broccoli, V., Böckers, T. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.258384 · Cited by 197
Mutations in the calcium-related gene IL1RAPL1 are associated with autism
Piton, A., Michaud, J. L., Peng, H., Aradhya, S., Gauthier, J., Mottron, L., Champagne, N., Lafreniere, R. G., Hamdan, F. F., S2D team, et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn300 · Cited by 195
“Causal mutations in the synaptic genes NLGN4, NLGN3 (4) and SHANK3 (5) have been identified and independently confirmed by other teams (6 – 9).”
Walsh, C. A., Morrow, E. M., & Rubenstein, J. L. R. (2008) · Cell · doi:10.1016/j.cell.2008.10.015 · Cited by 196
“The SHANK3 gene, which encodes a cytoplasmic binding partner of the neuroligins, was also identified based on a chromosomal deletion (Durand et al., 2007).”
BackgroundDisruption at the PTCHD1 Locus on Xp22.11 in Autism Spectrum Disorder and Intellectual Disability
Noor, A., Whibley, A., Marshall, C. R., Gianakopoulos, P. J., Piton, A., Carson, A. R., Orlic-Milacic, M., Lionel, A. C., Sato, D., Pinto, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001267 · Cited by 193
“CNV studies have also led to the identification of autism candidate genes such as SHANK3 (MIM 606230) and NRXN1 (MIM 600565) (1,4,5).”
Autism genetics: searching for specificity and convergence
Berg, J. M., & Geschwind, D. H. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-247 · Cited by 192
“synaptic scaffolding proteins SHANK2 and SHANK3, identified as ASD risk factors in several studies [27,52, 124,125].”
BackgroundAutism: A world changing too fast for a mis-wired brain?
Gepner, B., & Féron, F. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.006 · Cited by 191
“Another gene, SHANK3 (located in the 22q13 region), a neuroligin-binding partner regulating the structural organization of dendritic spines, has been found to be deleted in two brothers with ASD and delayed expressive speech (Durand et al., 2007).”
BackgroundClinical and genomic evaluation of 201 patients with Phelan–McDermid syndrome
Sarasua, S. M., Boccuto, L., Sharp, J. L., Dwivedi, A., Chen, C.-F., Rollins, J. D., Rogers, R. C., Phelan, K., & DuPont, B. R. (2014) · Human Genetics · doi:10.1007/s00439-014-1423-7 · Cited by 190
Betancur, C., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-17 · Cited by 189
“3 deletions and mutations that lead to a loss of a functional copy of SHANK3 cause Phelan-McDermid syndrome, characterized by moderate to profound intellectual disability, severely delayed or absent speech, hypotonia, and ASD or ASD traits [2,3].”
Self-citationGenetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders
Rossignol, E. (2011) · Neural Plasticity · doi:10.1155/2011/649325 · Cited by 188
The possible interplay of synaptic and clock genes in autism spectrum disorders
Bourgeron, T. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.020 · Cited by 185
Self-citationStructures and target recognition modes of PDZ domains: recurring themes and emerging pictures
Ye, F., & Zhang, M. (2013) · Biochemical Journal · doi:10.1042/bj20130783 · Cited by 182
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism
Wang, W., Li, C., Chen, Q., van der Goes, M.-S., Hawrot, J., Yao, A. Y., Gao, X., Lu, C., Zang, Y., Zhang, Q., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87997 · Cited by 182
“PMS is a neurodevelopmental disorder characterized by intellectual disability, autistic-like behaviors, hypotonia, and impaired development of speech and language (23, 24).”
The clinical context of copy number variation in the human genome
Lee, C., & Scherer, S. W. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001390 · Cited by 182
Zhang, C., Milunsky, J. M., Newton, S., Ko, J., Zhao, G., Maher, T. A., Tager-Flusberg, H., Bolliger, M. F., Carter, A. S., Boucard, A. A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1248-09.2009 · Cited by 182
“…and in SHANK3 [which binds to NLs intracellularly via PSD-95 (Naisbitt et al., 1999)] have also been associated with ASDs (Jeffries et al., 2005; Durand et al., 2007; Szatmari et al., 2007; Marshall et al., 2008; Morrow et al., 2008; Kim et al., 2009), suggesting a synaptic pathway for ASD…”
BackgroundInfluentialNeuroligin-1–dependent competition regulates cortical synaptogenesis and synapse number
Kwon, H.-B., Kozorovitskiy, Y., Oh, W.-J., Peixoto, R. T., Akhtar, N., Saulnier, J. L., Gu, C., & Sabatini, B. L. (2012) · Nature Neuroscience · doi:10.1038/nn.3256 · Cited by 181
“Similar morphological changes were observed in biolistically transfected hippocampal CA1 pyramidal neurons in organotypic slice cultures ( Supplementary Fig.”
BackgroundLesca, G., Rudolf, G., Labalme, A., Hirsch, E., Arzimanoglou, A., Genton, P., Motte, J., de Saint Martin, A., Valenti, M., Boulay, C., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03559.x · Cited by 181
“Last but not least, pathogenic mutations in SHANK3 at 22q13 have been found in patients with ASD and with language impairment (Durand et al., 2007); of interest, the large deletion containing SHANK3 was detected in one of the two patients (DY34) with marked autistic features.”
BackgroundBehavioral phenotypes of genetic mouse models of autism
Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12256 · Cited by 178
“Genetic studies have identified de novo and inherited mutations in SHANK1 (Sato et al. 2012), SHANK2 (Berkel et al. 2010, 2012; Pinto et al. 2010) and SHANK3 (Boccuto et al. 2013; Durand et al. 2007; Gauthier et al. 2009, 2010; Marshall et al. 2008; Moessner et al. 2007).”
BackgroundMethodAutistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Lintas, C., & Persico, A. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060871 · Cited by 178
“In vitro overexpression of these variants resulted in diminished colocalisation with the pre-synaptic marker protein Bassoon, suggesting nonsynaptic clustering of mutated SHANK3.”
BackgroundResultInfluentialGriswold, A. J., Ma, D., Cukier, H. N., Nations, L. D., Schmidt, M. A., Chung, R.-H., Jaworski, J. M., Salyakina, D., Konidari, I., Whitehead, P. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds164 · Cited by 175
“3 which removes SHANK3 and results in Phelan-McDermid syndrome.”
BackgroundInfluentialBalasco, L., Provenzano, G., & Bozzi, Y. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.01016 · Cited by 177
SHANK3 as an autism spectrum disorder-associated gene
Uchino, S., & Waga, C. (2013) · Brain and Development · doi:10.1016/j.braindev.2012.05.013 · Cited by 176
“[11] reported finding eight non-synonymous mutations in ASD patients that were not present in healthy controls, and several of the mutations had an effect on dendritic spine morphology and synaptic transmission [15].”
BackgroundInfluentialSala, C., Vicidomini, C., Bigi, I., Mossa, A., & Verpelli, C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13232 · Cited by 175
Gene and miRNA expression profiles in autism spectrum disorders
Ghahramani Seno, M. M., Hu, P., Gwadry, F. G., Pinto, D., Marshall, C. R., Casallo, G., & Scherer, S. W. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.046 · Cited by 177
“Contribution of SHANK3 mutations to autism spectrum disorder.”
InfluentialOligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., Lewis, L., Akbar, H., Varghese, R., Boerwinkle, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr243 · Cited by 175
Grabrucker, S., Jannetti, L., Eckert, M., Gaub, S., Chhabra, R., Pfaender, S., Mangus, K., Reddy, P. P., Rankovic, V., Schmeisser, M. J., et al. (2014) · Brain · doi:10.1093/brain/awt303 · Cited by 175
Self-citationAutism spectrum disorder in the genetics clinic: a review
Carter, M., & Scherer, S. (2013) · Clinical Genetics · doi:10.1111/cge.12101 · Cited by 174
“SHANK3 was first implicated in idiopathic ASD when a de novo deletion with a breakpoint within a SHANK3 intron was discovered (86).”
BackgroundKlune, C. B., Jin, B., & DeNardo, L. A. (2021) · eLife · doi:10.7554/elife.64567 · Cited by 174
Arons, M. H., Thynne, C. J., Grabrucker, A. M., Li, D., Schoen, M., Cheyne, J. E., Boeckers, T. M., Montgomery, J. M., & Garner, C. C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2215-12.2012 · Cited by 175
“Autism spectrum disorders (ASDs) are a set of neurodevelopmental disorders characterized by impairments in communication and social behavior and by repetitive or stereotyped behaviors (Bailey et al., 1996; Miles, 2011).”
BackgroundInfluentialSelf-citationGPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies
Bockaert, J., Perroy, J., Bécamel, C., Marin, P., & Fagni, L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105705 · Cited by 175
Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains
Geisheker, M. R., Heymann, G., Wang, T., Coe, B. P., Turner, T. N., Stessman, H. A. F., Hoekzema, K., Kvarnung, M., Shaw, M., Friend, K., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4589 · Cited by 174
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5003 · Cited by 170
“[PubMed: 22463983] Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, MourenSimeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T. Mutations in the gene encod…”
BackgroundInfluentialDhamne, S. C., Silverman, J. L., Super, C. E., Lammers, S. H. T., Hameed, M. Q., Modi, M. E., Copping, N. A., Pride, M. C., Smith, D. G., Rotenberg, A., et al. (2017) · Molecular Autism · doi:10.1186/s13229-017-0142-z · Cited by 171
PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity
Xu, W. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.03.001 · Cited by 171
“Furthermore, within the array of interaction partners, several were identified in genetic studies of neuropsychiatric and neurodevelopmental disorders, including neuroligins in autism spectrum disorder [6], SAPAP3 in obsessive compulsive disorder [7], and its interaction partner SHANK family proteins in ASD [8] [9], p…”
Li, J., Ashley, J., Budnik, V., & Bhat, M. A. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.002 · Cited by 170
Richter, M., Murtaza, N., Scharrenberg, R., White, S. H., Johanns, O., Walker, S., Yuen, R. K. C., Schwanke, B., Bedürftig, B., Henis, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0025-5 · Cited by 169
Poultney, C. S., Goldberg, A. P., Drapeau, E., Kou, Y., Harony-Nicolas, H., Kajiwara, Y., De Rubeis, S., Durand, S., Stevens, C., Rehnström, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.001 · Cited by 169
Rosenfeld, J. A., Ballif, B. C., Torchia, B. S., Sahoo, T., Ravnan, J. B., Schultz, R., Lamb, A., Bejjani, B. A., & Shaffer, L. G. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f0c5f3 · Cited by 169
Kang, S. L., Shaw, C., Ou, Z., Eng, P. A., Cooper, M. L., Pursley, A. N., Sahoo, T., Bacino, C. A., Chinault, A. C., Stankiewicz, P., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33278 · Cited by 168
“Deletions of, and mutations in, this gene have been associated with language and speech delay, and autistic spectrum disorder [Durand et al., 2007].”
BackgroundE-I balance and human diseases – from molecules to networking
Eichler, S. A. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2008 · Cited by 167
“For example, increased AMPA-to-NMDA receptor ratios were found in patients affl icted with Alzheimer’s disease (Snyder et al., 2005) and schizophrenia (Mohn et al., 1999).”
BackgroundWang, X., Xu, Q., Bey, A. L., Lee, Y., & Jiang, Y.-H. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-30 · Cited by 169
“5% of ASD patients with variable clinical presentations [10-14].”
BackgroundInfluentialMikhail, F. M., Lose, E. J., Robin, N. H., Descartes, M. D., Rutledge, K. D., Rutledge, S. L., Korf, B. R., & Carroll, A. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34177 · Cited by 168
Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat
Harony-Nicolas, H., Kay, M., Hoffmann, J. D., Klein, M. E., Bozdagi-Gunal, O., Riad, M., Daskalakis, N. P., Sonar, S., Castillo, P. E., Hof, P. R., et al. (2017) · eLife · doi:10.7554/elife.18904 · Cited by 168
“(A) The top schematic shows the Shank3 protein domains [ankyrin repeats domain (ANK), a Src homology 3 (SH3) domain, a PDZ domain, and a sterile a-motif (SAM) domain] and indicates the published de novo mutations observed within the ANK domain in PMS patients (light blue text, top schematic) (Durand et al., 2007; Moes…”
BackgroundUnifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
“(2) Reviews of ASD that categorize genes according to prop- erties of the proteins they encode, such as their anatomical location (Ebert and Greenberg, 2013; Toro et al., 2010; Uzunova et al., 2014), their protein-protein interactions with other gene products (Sakai et al., 2011), or their…”
InfluentialSynaptic proteins and receptors defects in autism spectrum disorders
Chen, J., Yu, S., Fu, Y., & Li, X. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00276 · Cited by 167
“Three ASDs families were observed to carry alterations of 22q and/or the SHANK3 gene (Durand et al., 2007).”
BackgroundAutism and the synapse: emerging mechanisms and mechanism-based therapies
Ebrahimi-Fakhari, D., & Sahin, M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000186 · Cited by 167
The Genetics of Autism: Key Issues, Recent Findings, and Clinical Implications
El-Fishawy, P., & State, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.002 · Cited by 166
“[17,68,69]”
BackgroundYoshida, T., Yasumura, M., Uemura, T., Lee, S.-J., Ra, M., Taguchi, R., Iwakura, Y., & Mishina, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2136-11.2011 · Cited by 166
“Interestingly, some genetic loci are also overlapping in susceptibility to these disorders (Jamain et al., 2003; Laumonnier et al., 2004; Durand et al., 2007; Kim et al., 2008; Berkel et al., 2010; Laumonnier et al., 2010).”
BackgroundResultFetal exposure to teratogens: Evidence of genes involved in autism
Dufour-Rainfray, D., Vourc’h, P., Tourlet, S., Guilloteau, D., Chalon, S., & Andres, C. R. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.013 · Cited by 167
Downregulation of NR3A-Containing NMDARs Is Required for Synapse Maturation and Memory Consolidation
Roberts, A. C., Díez-García, J., Rodriguiz, R. M., López, I. P., Luján, R., Martínez-Turrillas, R., Picó, E., Henson, M. A., Bernardo, D. R., Jarrett, T. M., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.016 · Cited by 166
“Accumulating evidence suggests that failure to achieve the appropriate balance results in a number of CNS disorders ranging from schizophrenia to autism and mental retardation (Bagni and Greenough, 2005; Chao et al., 2007; Durand et al., 2007; Frankle et al., 2003).”
SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons
Han, Q., Kim, Y. H., Wang, X., Liu, D., Zhang, Z.-J., Bey, A. L., Lay, M., Chang, W., Berta, T., Zhang, Y., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.11.007 · Cited by 164
“It is noteworthy that human SHANK3 mutation InsG3680 resulted in a truncated SHANK3 ending at the site 1,227 of the Proline-rich891–1,299 region (Durand et al., 2007), and this mutation also affected TRPV1 function in DRG neurons (Figure 3E).”
InfluentialAutism Spectrum Disorders: Etiology and Pathology
Sauer, A. K., Stanton, J. E., Hans, S., & Grabrucker, A. M. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.etiology · Cited by 276
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.